(Date:7/25/2008)...on Significant Improvements in Members, Health, A... leader in health,care quality management solution...it has entered into a long-term agreement with Wel...aboration on Quality(SM) Incent and,Reward Best Pr...rk and,primary care clinicians to promote improved...
(Date:7/25/2008)...ire/ -- The Elekta Family of Companies will,showca... at the 2008,American Association of Physicists in... the joint forces of Elekta, IMPAC and CMS are del...d delivery solutions that,streamline the treatment...s, as well as enhance clinician efficiency., "Our...
(Date:7/25/2008)...esophagus can cause immune system changes , ...t evidence linking gastroesophageal reflux disease...versity Medical Center researchers. , An associ...n the 1970s, and since then studies have shown tha...ents also experience GERD symptoms. But the actual...
(Date:7/25/2008)... Retina Group of New York will present an educatio...tion especially designed for seniors. The lecture ...116 Merritts Road, Farmingdale, NY 11735, 1:00 to ... and refreshments will be provided. The phone numb... Hicksville and Hauppauge, NY (...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3(Date:7/24/2008)...July 24 /- Alexza,Pharmaceu... it has initiated,its second Phase 3 clinical tria... inhalation product candidate being developed for ...schizophrenia or bipolar disorder.,Alexza believes...kinetic,(PK) properties resulting from inhaled lox...
(Date:7/24/2008)...er designed to take body temperature, for home,and...FirstCall/ --- Kidz-Med, Inc.,(subsidiary of Ameri...United States distributor of the Thermofocus(R) 5-...ce the results of a clinical study,conducted by th...lan, in,Milan, Italy, which proves that the Thermo...
(Date:7/23/2008)...ublication in July print edition of Clinical ...ANAPOLIS, July 23 /- A Roche Diagnost...terminal pro-B-type natriuretic peptide,(NT-proBNP...sk,stratification in predicting the risk of cardio...d with non-steroidal anti-inflammatory drugs of,th...
(Date:7/23/2008)...reas of the Body Have Greater Concentrations of,St...swire-USNewswire/ -- Fat removed,from the lower ab...d to be,an excellent source of stem cells, with hi...the body, reports a Brazilian-based study in Augus...icial medical journal of the,American Society of P...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 1Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 3Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 4Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 5Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 6Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 7Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 8Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 9Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 10In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 1In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 1FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 3FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 4FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 5Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 1Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 2Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 3... Statistically Significant Changes in,Agitation Le...6, 2007 /PRNewswire-FirstCall/ --,Alexza Pharmaceu...lts from its Phase IIa clinical trial of AZ-004 (S...h acute agitation. The 10 mg,dose of AZ-004 met th...s a statistically-significant reduction in the mea...
...esented at Keystone Scientific Meeting, SOUTH SAN ...tCall/ -- Rigel today announced that Yonchu,Jenkin...presenting,on the company,s efforts to develop a s...he Human Immunodeficiency Virus (HIV),infection at...ch,27th and 29th. Dr. Jenkins will present both a ...
Other Medicine Technology:Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 2Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV,Activity 3Horizontal Mini Gel Kit. Gel Bed dimensions: 7.5cm(w) x 10cm(l). Includes one comb and tapered baffles for casting in the unit. Gel bed is UV transparent. Available in clear, blue, yellow, pink,
... gels offer many advantages for nucleic acid separ...cular biologist. Agarose gels are easy to cast and...nderlaying and prevent electrical field discontinu...Horizontal systems are more economical and easier ...
The Mini-Sub cell GT system, with 7 x 10 cm tray, is used for submerged horizontal gel electrophoresis of nucleic acids in mini format 7 x 10 cm agarose gels. The system includes an electrophoresis c
Wide Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 20-well, 32-well, and 2 x 32-well wide mini ReadyAgarose gels
Medicine Products: